|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Masuda M, Kuwano H, Okumura M, Arai H,
Endo S, Doki Y, Kobayashi J, Motomura N, Nishida H, Saiki Y, et al:
Thoracic and cardiovascular surgery in Japan during 2013: Annual
report by The Japanese association for thoracic surgery. Gen Thorac
Cardiovasc Surg. 63:670–701. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
De Leyn P, Lardinois D, Van Schil P,
Rami-Porta R, Passlick B, Zielinski M, Waller D, Lerut T and Weder
W: European trends in preoperative and intraoperative nodal
staging: ESTS guidelines. J Thorac Oncol. 2:357–361.
2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Howington JA, Blum MG, Chang AC, Balekian
AA and Murthy SC: Treatment of stage I and II non-small cell lung
cancer: Diagnosis and management of lung cancer, 3rd ed: American
College of Chest Physicians evidence-based clinical practice
guidelines. Chest. 143:e278S–e313S. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ishiguro F, Matsuo K, Fukui T, Mori S,
Hatooka S and Mitsudomi T: Effect of selective lymph node
dissection based on patterns of lobe-specific lymph node metastases
on patient outcome in patients with resectable non-small cell lung
cancer: A large-scale retrospective cohort study applying a
propensity score. J Thorac Cardiovasc Surg. 139:1001–1006.
2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Maniwa T, Okumura T, Isaka M, Nakagawa K,
Ohde Y and Kondo H: Recurrence of mediastinal node cancer after
lobe-specific systematic nodal dissection for non-small-cell lung
cancer. Eur J Cardiothorac Surg. 44:e59–e64. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hishida T, Miyaoka E, Yokoi K, Tsuboi M,
Asamura H, Kiura K, Takahashi K, Dosaka-Akita H, Kobayashi H, Date
H, et al: Lobe-specific nodal dissection for clinical stage I and
II NSCLC: Japanese multi-institutional retrospective study using a
propensity score analysis. J Thorac Oncol. 11:1529–1537.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Adachi H, Sakamaki K, Nishii T, Yamamoto
T, Nagashima T, Ishikawa Y, Ando K, Yamanaka K, Watanabe K,
Kumakiri Y, et al: Lobe-specific lymph node dissection as a
standard procedure in surgery for non-small cell lung cancer: A
propensity score matching study. J Thorac Oncol. 12:85–93.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Okada M, Sakamoto T, Yuki T, Mimura T,
Miyoshi K and Tsubota N: Selective mediastinal lymphadenectomy for
clinico-surgical stage I non-small cell lung cancer. Ann Thorac
Surg. 81:1028–1032. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Darling GE, Allen MS, Decker PA, Ballman
K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ,
Rusch VW and Putnam JB Jr: Randomized trial of mediastinal lymph
node sampling versus complete lymphadenectomy during pulmonary
resection in the patient with N0 or N1 (less than hilar) non-small
cell carcinoma: Results of the American college of surgery oncology
group z0030 trial. J Thorac Cardiovasc Surg. 141:662–670.
2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hughes MJ, Chowdhry MF, Woolley SM and
Walker WS: In patients undergoing lung resection for non-small cell
lung cancer, is lymph node dissection or sampling superior?
Interact Cardiovasc Thorac Surg. 13:311–315. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li H, Han D, Hou Y, Chen H and Chen Z:
Statistical inference methods for two crossing survival curves: A
comparison of methods. PLoS One. 10(e0116774)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lardinois D, De Leyn P, Van Schil P, Porta
RR, Waller D, Passlick B, Zielinski M, Lerut T and Weder W: ESTS
guidelines for intraoperative lymph node staging in non-small cell
lung cancer. Eur J Cardiothorac Surg. 30:787–792. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rice D, Chansky K, Nowak A, Pass H,
Kindler H, Shemanski L, Opitz I, Call S, Hasegawa S, Kernstine K,
et al: The IASLC mesothelioma staging project: Proposals for
revisions of the N descriptors in the forthcoming eighth edition of
the TNM classification for pleural mesothelioma. J Thorac Oncol.
11:2100–2111. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chansky K, Detterbeck FC, Nicholson AG,
Rusch VW, Vallières E, Groome P, Kennedy C, Krasnik M, Peake M,
Shemanski L, et al: The IASLC lung cancer staging project: External
validation of the revision of the TNM stage groupings in the eighth
edition of the TNM classification of lung cancer. J Thorac Oncol.
12:1109–1121. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jett JR, Schild SE, Kesler KA and
Kalemkerian GP: Treatment of small cell lung cancer: Diagnosis and
management of lung cancer, 3rd ed: American College of Chest
Physicians evidence-based clinical practice guidelines. Chest.
143:e400S–e419S. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Adachi H, Maehara T, Nakayama H and Masuda
M: Mediastinal lymph node dissection in surgical treatment for
early stage non-small-cell lung cancer: Lobe-specific or
systematic? J Thorac Dis. 9:2728–2731. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ma K, Chang D, He B, Gong M, Tian F, Hu X,
Ji Z and Wang T: Radical systematic mediastinal lymphadenectomy
versus mediastinal lymph node sampling in patients with clinical
stage IA and pathological stage T1 non-small cell lung cancer. J
Cancer Res Clin Oncol. 134:1289–1295. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Goldstraw P: Report on the international
workshop on intrathoracic staging. London, October 1996. Lung
Cancer. 18:107–111. 1997.
|
|
21
|
Wu Y, Huang ZF, Wang SY, Yang XN and Ou W:
A randomized trial of systematic nodal dissection in resectable
non-small cell lung cancer. Lung Cancer. 36:1–6. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Keller SM, Adak S, Wagner H and Johnson
DH: Mediastinal lymph node dissection improves survival in patients
with stages II and IIIa non-small cell lung cancer. Eastern
cooperative oncology group. Ann Thorac Surg. 70:358–365; discussion
365-356. 2000.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Misthos P, Sepsas E, Kokotsakis J, Skottis
I and Lioulias A: Prognosis of stage pIIIA non small cell lung
cancer after mediastinal lymph node dissection or sampling. J BUON.
14:45–49. 2009.PubMed/NCBI
|
|
24
|
Doddoli C, Aragon A, Barlesi F, Chetaille
B, Robitail S, Giudicelli R, Fuentes P and Thomas P: Does the
extent of lymph node dissection influence outcome in patients with
stage I non-small-cell lung cancer? Eur J Cardiothorac Surg.
27:680–685. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Allen MS, Darling GE, Pechet TT, Mitchell
JD, Herndon JE II, Landreneau RJ, Inculet RI, Jones DR, Meyers BF,
Harpole DH, et al: Morbidity and mortality of major pulmonary
resections in patients with early-stage lung cancer: Initial
results of the randomized, prospective ACOSOG Z0030 trial. Ann
Thorac Surg. 81:1013–1019; discussion 1019-1020. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bille A, Woo KM, Ahmad U, Rizk NP and
Jones DR: Incidence of occult pN2 disease following resection and
mediastinal lymph node dissection in clinical stage I lung cancer
patients. Eur J Cardiothorac Surg. 51:674–679. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Huang X, Wang J, Chen Q and Jiang J:
Mediastinal lymph node dissection versus mediastinal lymph node
sampling for early stage non-small cell lung cancer: A systematic
review and meta-analysis. PLoS ONE. 9(e109979)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Watanabe S: Lymph node dissection for lung
cancer: Past, present, and future. Gen Thorac Cardiovasc Surg.
62:407–414. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Meng D, Zhou Z, Wang Y, Wang L, Lv W and
Hu J: Lymphadenectomy for clinical early-stage non-small-cell lung
cancer: A systematic review and meta-analysis. Eur J Cardiothorac
Surg. 50:597–604. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Samayoa AX, Pezzi TA, Pezzi CM, Gay EG,
Asai M, Kulkarni N, Carp N, Chun SG and Putnam JB Jr: Rationale for
a minimum number of lymph nodes removed with non-small cell lung
cancer resection: Correlating the number of nodes removed with
survival in 98,970 patients. Ann Surg Oncol. 23:1005–1011.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liang W, He J, Shen Y, Shen J, He Q, Zhang
J, Jiang G, Wang Q, Liu L, Gao S, et al: Impact of examined lymph
node count on precise staging and long-term survival of resected
non-small-cell lung cancer: A population study of the US SEER
database and a Chinese multi-institutional registry. J Clin Oncol.
35:1162–1170. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Riquet M, Arame A and Pricopi C:
Subcarinal lymph node importance revisited. Ann Thorac Surg.
105:666–667. 2018.PubMed/NCBI View Article : Google Scholar
|
